Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohide Hanawa

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Respirology Case Reports|July 14, 2026
Good Syndrome Presenting With Pulmonary Abnormalities Four Years After ThymectomyTomohide Hanawa, Tomohiro Akaba, Yuka Kaizu, et al.
BMC Endocrine Disorders|January 5, 2023
Reduced antibody response to SARS-CoV-2 in COVID-19 patients with newly diagnosed diabetes: a retrospective observational studyNaoya Otsubo, Tatsuya Fukuda, Hiroko Beppu, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 19, 2023
Comparative outcomes of hemodialysis patients facing pre-Omicron and Omicron COVID-19 epidemicsHiroko Beppu, Tatsuya Fukuda, Naoya Otsubo, et al.
Nephrology (Carlton, Vic.)|February 22, 2023
Serum chemokine CC-motif ligand 17 is a predictive marker of severe COVID-19 in haemodialysis patients: A retrospective observational studyHiroko Beppu, Tatsuya Fukuda, Naoya Otsubo, et al.
Clinical and Experimental Nephrology|September 6, 2021
Hemodialysis patients with coronavirus disease 2019: reduced antibody responseHiroko Beppu, Tatsuya Fukuda, Tomoko Kawanishi, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Respirology Case Reports|July 14, 2026
Good Syndrome Presenting With Pulmonary Abnormalities Four Years After ThymectomyTomohide Hanawa, Tomohiro Akaba, Yuka Kaizu, et al.
BMC Endocrine Disorders|January 5, 2023
Reduced antibody response to SARS-CoV-2 in COVID-19 patients with newly diagnosed diabetes: a retrospective observational studyNaoya Otsubo, Tatsuya Fukuda, Hiroko Beppu, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 19, 2023
Comparative outcomes of hemodialysis patients facing pre-Omicron and Omicron COVID-19 epidemicsHiroko Beppu, Tatsuya Fukuda, Naoya Otsubo, et al.
Nephrology (Carlton, Vic.)|February 22, 2023
Serum chemokine CC-motif ligand 17 is a predictive marker of severe COVID-19 in haemodialysis patients: A retrospective observational studyHiroko Beppu, Tatsuya Fukuda, Naoya Otsubo, et al.
Clinical and Experimental Nephrology|September 6, 2021
Hemodialysis patients with coronavirus disease 2019: reduced antibody responseHiroko Beppu, Tatsuya Fukuda, Tomoko Kawanishi, et al.
Pageof 1